Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 17 Beta-hydroxyandrosta-1,4-dien-3-one 10-undecenoate
2. 3-oxo-1,4-androstadiene-17-ol Undecylenate
3. Ba 29038
4. Equipoise
5. Parenabol
1. 13103-34-9
2. Equipoise
3. Vebonol
4. Parenabol
5. 17b-[(1-oxo-10-undecenyl)oxy]-androsta-1,4-dien-3-one
6. Boldenone 10-undecenoate
7. Ba-29038
8. Boldenone Undecylenate [usan]
9. Ba 29038
10. Androsta-1,4-dien-3-one, 17-[(1-oxo-10-undecenyl)oxy]-, (17b)-
11. Zs6d2ita30
12. 17b-((1-oxo-10-undecenyl)oxy)-androsta-1,4-dien-3-one
13. 17beta-hydroxyandrosta-1,4-dien-3-one 10-undecenoate
14. Boldenone Undec-10-enoate
15. Boldenone Undecylenate (usan)
16. (8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-17-yl Undec-10-enoate
17. [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] Undec-10-enoate
18. Equipoise (veterinary)
19. Unii-zs6d2ita30
20. Androstadienolone Undecylenate
21. Equipoise (tn)
22. Einecs 236-024-5
23. Boldenone Undecenoate
24. Brn 2402671
25. 17.beta.-hydroxyandrosta-1,4-dien-3-one 10-undecenoate
26. Chembl2106059
27. Schembl21804358
28. Dtxsid00156854
29. Androsta-1,4-diene-3-one, 17-((1-oxo-10-undecenyl)oxy)-, (17.beta.)-
30. Zinc4215044
31. Mfcd00079126
32. S3715
33. Boldenone Undecenoate [mart.]
34. Akos016003765
35. Androsta-1,4-diene-3-one, 17-((1-oxo-10-undecenyl)oxy)-, (17beta)-
36. Boldenone 10-undecenoate [mi]
37. Ccg-269262
38. Cs-1418
39. Db14639
40. Ncgc00378669-02
41. Ac-28715
42. As-33134
43. Hy-17434
44. Boldenone Undecylenate [green Book]
45. D03145
46. 103b349
47. Boldenone Undecylenate 1.0 Mg/ml In Acetonitrile
48. W-108342
49. 3-oxoandrosta-1,4-dien-17-yl 10-undecenoate
50. Q27295867
51. Androsta-1,4-dien-3-one, 17-beta-hydroxy-, 10-undecenoate
52. Androsta-1,4-dien-3-one, 17-((1-oxo-10-undecenyl)oxy)-, (17-beta)-
| Molecular Weight | 452.7 g/mol |
|---|---|
| Molecular Formula | C30H44O3 |
| XLogP3 | 8.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 11 |
| Exact Mass | 452.32904526 g/mol |
| Monoisotopic Mass | 452.32904526 g/mol |
| Topological Polar Surface Area | 43.4 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 807 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
The activity of boldenone is mainly anabolic, with a low androgenic potency. The drug is commonly used in doping within bodybuilding, even though this use is illegal. If intended to assist in bodybuilding, the drug is taken as part of a steroid stack of other anabolic steroids, usually with a potent androgen like testosterone as the 'base' of the stack. Boldenone is an androgen that differs from 17b-testosterone (17b-T) by only one double bond at the 1-position, and the removal of the methyl group protecting the 17-OH group allows it to be orally active.
14 days
Boldenone is a steroid hormone which has androgenic activity. Androgens bind to the androgen receptor, which regulates gene transcription.
API SUPPLIERS
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5370
Submission : 1984-03-28
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3827
Submission : 1980-05-21
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
97
PharmaCompass offers a list of Boldenone Undecylenate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Boldenone Undecylenate manufacturer or Boldenone Undecylenate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Boldenone Undecylenate manufacturer or Boldenone Undecylenate supplier.
PharmaCompass also assists you with knowing the Boldenone Undecylenate API Price utilized in the formulation of products. Boldenone Undecylenate API Price is not always fixed or binding as the Boldenone Undecylenate Price is obtained through a variety of data sources. The Boldenone Undecylenate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vebonol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vebonol, including repackagers and relabelers. The FDA regulates Vebonol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vebonol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vebonol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vebonol supplier is an individual or a company that provides Vebonol active pharmaceutical ingredient (API) or Vebonol finished formulations upon request. The Vebonol suppliers may include Vebonol API manufacturers, exporters, distributors and traders.
click here to find a list of Vebonol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vebonol DMF (Drug Master File) is a document detailing the whole manufacturing process of Vebonol active pharmaceutical ingredient (API) in detail. Different forms of Vebonol DMFs exist exist since differing nations have different regulations, such as Vebonol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vebonol DMF submitted to regulatory agencies in the US is known as a USDMF. Vebonol USDMF includes data on Vebonol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vebonol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vebonol suppliers with USDMF on PharmaCompass.
Vebonol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vebonol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vebonol GMP manufacturer or Vebonol GMP API supplier for your needs.
A Vebonol CoA (Certificate of Analysis) is a formal document that attests to Vebonol's compliance with Vebonol specifications and serves as a tool for batch-level quality control.
Vebonol CoA mostly includes findings from lab analyses of a specific batch. For each Vebonol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vebonol may be tested according to a variety of international standards, such as European Pharmacopoeia (Vebonol EP), Vebonol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vebonol USP).
